Illustrated Sterling Clark
On June 10, 1957, the Food and Drug Administration (FDA) approved Enovid 10 mg (9.85 mg norethynodrel and 150 µg mestranol) for menstrual disorders, based on data from its use by more than 600 women.
Copyright
Times Illustrated by Julie and Julien Libersat is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.